Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.2K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Allergic Reactions02:06

Allergic Reactions

30.7K
Overview
30.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

1.5K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceived Stress Change During a Mindfulness-Based Intervention for Emotional Distress: Integrated Evidence From Two Randomized Trials.

Clinical psychology & psychotherapy·2026
Same author

Benchmark Survey on Content Development and Key Performance Indicators: A phactMI Benchmarking Survey Update.

Therapeutic innovation & regulatory science·2026
Same author

Temporal Precedence of Distress Tolerance in Predicting Anxiety and Depression: A Daily Diary Approach During Mindfulness-Based Intervention.

Behavior therapy·2026
Same author

Best Practices for Medical Information Global Response Documents from phactMI and MILE.

Pharmaceutical medicine·2026
Same author

Pharmacist-led medication safety interventions to reduce long-acting injectable-related medication incidents during community-to-inpatient transitions of care.

The mental health clinician·2025
Same author

Key informant perspectives on facilitators for pharmacist payment of medication therapy management services.

Journal of the American Pharmacists Association : JAPhA·2025

Related Experiment Video

Updated: Dec 2, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.0K

Emerging Therapies for Peanut Allergy.

Thomas S Hong1, Amy Hu1, Germin Fahim1

  • 1Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.

Journal of Pharmacy Practice
|November 5, 2020
PubMed
Summary

New peanut allergy (PA) immunotherapies show promise for treating this growing public health concern. While effective, these treatments carry risks and require further study before widespread adoption.

Keywords:
epicutaneous immunotherapyoral immunotherapypeanut allergysublingual immunotherapy

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.7K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.8K

Related Experiment Videos

Last Updated: Dec 2, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.0K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.7K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.8K

Area of Science:

  • Allergy and Immunology
  • Food Hypersensitivity Research
  • Clinical Therapeutics

Background:

  • Peanut allergy (PA) is a significant public health issue, affecting 2% of US children.
  • Current PA management relies on allergen avoidance and emergency medication.
  • IgE-mediated hypersensitivity reactions characterize PA.

Purpose of the Study:

  • To review emerging therapies for peanut allergy.
  • To evaluate the potential of novel immunotherapies in PA treatment.
  • To assess the efficacy and safety of new PA treatment modalities.

Main Methods:

  • Review of clinical trials for oral, epicutaneous, and sublingual immunotherapies.
  • Evaluation of adjuvant combinations (probiotics, anti-IgE receptor antagonists).
  • Analysis of safety and efficacy data for emerging PA treatments.

Main Results:

  • Oral immunotherapy (e.g., Palforzia) and epicutaneous immunotherapy (e.g., Viaskin Peanut) show promising efficacy.
  • Adjuvant combinations demonstrate improved efficacy and safety over oral immunotherapy alone.
  • High rates of adverse reactions are noted due to intentional allergen exposure.

Conclusions:

  • Emerging immunotherapies offer a promising future for peanut allergy treatment.
  • Further research is necessary to establish these therapies in standard clinical care.
  • Balancing efficacy with the risks of immunotherapy-induced adverse reactions is crucial.